• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植脂肪变性和纤维化的早期诊断:非侵入性检查是答案吗?

Early diagnosis of liver graft steatosis and fibrosis: are non-invasive tests the answer?

作者信息

Dumont Colin, Iesari Samuele, Baldin Pamela, Aydin Selda, Henin Guillaume, Philippart Marie, Bonaccorsi-Riani Eliano, Ciccarelli Olga, Coubeau Laurent, Piessevaux Hubert, Lanthier Nicolas, Dahlqvist Géraldine

机构信息

Hepato-Gastroenterology Department, University Hospital Saint-Luc, Brussels, Belgium.

General Surgery and Kidney Transplantation, Foundation "IRCCS Ca' Granda Ospedale Maggiore Policlinico", Milan, Italy.

出版信息

Transl Gastroenterol Hepatol. 2025 Jun 26;10:51. doi: 10.21037/tgh-24-131. eCollection 2025.

DOI:10.21037/tgh-24-131
PMID:40755732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12314711/
Abstract

BACKGROUND

Graft steatosis and fibrosis detection is a challenge to avoid graft loss. The role of liver biopsy (LB) after liver transplantation (LT) is changing with the emergence of non-invasive tests. Our aim is to evaluate the accuracy of transient elastography (TE) in predicting steatosis and fibrosis post-LT.

METHODS

This prospective study was performed on 158 LT patients. Controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) were carried out prior to LB. We built receiver operating characteristic (ROC) curves to evaluate the predictive performance of TE.

RESULTS

Using CAP, the area under the curve (AUC) were 0.872 [95% confidence interval (CI): 0.791-0.953, P=0.01] and 0.708 (95% CI: 0.614-0.801, P<0.001) for the diagnosis of steatosis ≥ S2 and ≥ S1, respectively. Using LSM, the AUC were 0.588 (95% CI: 0.486-0.691, P=0.10) and 0.651 (95% CI: 0.480-0.822, P=0.10) for the diagnosis of fibrosis ≥ F2 and F3-F4, respectively. Cut-offs for CAP were 246.5 dB/m for S1 and 275.5 dB/m for S2. Cut-offs for LSM were 7.65 kPa for ≥ F2 and 9.25 kPa for ≥ F3.

CONCLUSIONS

TE may be useful for screening advanced fibrosis and, interestingly, steatosis after LT. TE might gain relevance to track graft metabolic dysfunction and to propose lifestyle interventions.

摘要

背景

移植肝脂肪变性和纤维化的检测对于避免移植肝失功是一项挑战。随着非侵入性检测方法的出现,肝移植(LT)后肝活检(LB)的作用正在发生变化。我们的目的是评估瞬时弹性成像(TE)预测LT后脂肪变性和纤维化的准确性。

方法

对158例LT患者进行了这项前瞻性研究。在LB之前进行受控衰减参数(CAP)和肝脏硬度测量(LSM)。我们绘制了受试者工作特征(ROC)曲线以评估TE的预测性能。

结果

使用CAP诊断脂肪变性≥S2和≥S1时,曲线下面积(AUC)分别为0.872 [95%置信区间(CI):0.791-0.953,P = 0.01]和0.708(95%CI:0.614-0.801,P<0.001)。使用LSM诊断纤维化≥F2和F3-F4时,AUC分别为0.588(95%CI:0.486-0.691,P = 0.10)和0.651(95%CI:0.480-0.822,P = 0.10)。S1的CAP临界值为246.5 dB/m,S2为275.5 dB/m。≥F2的LSM临界值为7.65 kPa,≥F3为9.25 kPa。

结论

TE可能有助于筛查LT后的晚期纤维化,有趣的是,也有助于筛查脂肪变性。TE可能在追踪移植肝代谢功能障碍和提出生活方式干预方面具有重要意义。

相似文献

1
Early diagnosis of liver graft steatosis and fibrosis: are non-invasive tests the answer?肝移植脂肪变性和纤维化的早期诊断:非侵入性检查是答案吗?
Transl Gastroenterol Hepatol. 2025 Jun 26;10:51. doi: 10.21037/tgh-24-131. eCollection 2025.
2
Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.评估瞬时弹性成像技术在诊断 MAFLD 中的应用,以及袖状胃切除术对中国人 MAFLD 的早期影响。
Int J Surg. 2024 Apr 1;110(4):2044-2054. doi: 10.1097/JS9.0000000000001078.
3
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
4
Prevalence of Hepatic Steatosis and Fibrosis in Asian Indian Individuals with Type 2 Diabetes.亚洲印度裔2型糖尿病患者肝脂肪变性和肝纤维化的患病率
Diabetes Ther. 2025 Jul 3. doi: 10.1007/s13300-025-01764-1.
5
Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C.基于四项因素(FIB-4)评分或 Forns 指数的成人慢性丙型肝炎肝纤维化分期。
Cochrane Database Syst Rev. 2024 Aug 13;8(8):CD011929. doi: 10.1002/14651858.CD011929.pub2.
6
Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.累积甲氨蝶呤剂量与有中重度银屑病病史患者的肝纤维化无关。
Br J Dermatol. 2024 Jul 16;191(2):275-283. doi: 10.1093/bjd/ljae069.
7
An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.应用磁共振弹性成像对非酒精性脂肪性肝病纤维化分期的截止值和混杂因素进行个体患者数据的荟萃分析。
J Hepatol. 2023 Sep;79(3):592-604. doi: 10.1016/j.jhep.2023.04.025. Epub 2023 Apr 29.
8
Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.安大略省使用瞬时弹性成像和受控衰减参数诊断肝纤维化和脂肪变性的经济学分析
Ont Health Technol Assess Ser. 2015 Nov 1;15(19):1-58. eCollection 2015.
9
Comparison of the magnetic resonance elastography and FIB-4 (MEFIB) Index and vibration-controlled transient elastography for significant metabolic dysfunction-associated steatotic liver disease fibrosis.磁共振弹性成像与FIB-4(MEFIB)指数及振动控制瞬时弹性成像在显著代谢功能障碍相关脂肪性肝病肝纤维化中的比较
Can Liver J. 2024 Dec 19;7(4):419-426. doi: 10.3138/canlivj-2024-0007. eCollection 2024 Dec.
10
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study.100 Hz 控制振动瞬时弹性成像测量脾脏硬度用于无创预测诊断代偿期慢性肝病进展期患者临床显著门静脉高压:模型研究。
Lancet Gastroenterol Hepatol. 2024 Dec;9(12):1111-1120. doi: 10.1016/S2468-1253(24)00234-6. Epub 2024 Sep 23.

本文引用的文献

1
Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short review.肝移植物的纤维化和脂肪变性:非侵入性检查是否有用?简短综述。
Clin Res Hepatol Gastroenterol. 2023 Oct;47(8):102194. doi: 10.1016/j.clinre.2023.102194. Epub 2023 Aug 9.
2
Genetic and Life Style Risk Factors for Recurrent Non-alcoholic Fatty Liver Disease Following Liver Transplantation.肝移植后复发性非酒精性脂肪性肝病的遗传和生活方式风险因素
Front Nutr. 2022 Jan 14;8:787430. doi: 10.3389/fnut.2021.787430. eCollection 2021.
3
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update.
EASL 临床实践指南:非侵入性检测评估肝脏疾病严重程度和预后——2021 更新版。
J Hepatol. 2021 Sep;75(3):659-689. doi: 10.1016/j.jhep.2021.05.025. Epub 2021 Jun 21.
4
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution.小儿肝移植后移植物纤维化:发生率、危险因素和演变。
Liver Transpl. 2022 Feb;28(2):280-293. doi: 10.1002/lt.26218. Epub 2021 Jul 31.
5
Noninvasive markers of liver steatosis and fibrosis after liver transplantation - Where do we stand?肝移植后肝脏脂肪变性和纤维化的非侵入性标志物——我们目前的进展如何?
World J Transplant. 2021 Mar 18;11(3):37-53. doi: 10.5500/wjt.v11.i3.37.
6
Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements.使用受控衰减参数和肝脏硬度测量评估肝移植受者的脂肪变性和纤维化。
Can J Gastroenterol Hepatol. 2021 Feb 8;2021:6657047. doi: 10.1155/2021/6657047. eCollection 2021.
7
Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients.微生物组分析和瞬时弹性成像揭示肥胖患者肝脂肪变性和纤维化的新肝外成分。
Sci Rep. 2021 Jan 12;11(1):659. doi: 10.1038/s41598-020-79718-9.
8
NAFLD and liver transplantation: Disease burden, current management and future challenges.非酒精性脂肪性肝病与肝移植:疾病负担、当前管理及未来挑战
JHEP Rep. 2020 Oct 9;2(6):100192. doi: 10.1016/j.jhepr.2020.100192. eCollection 2020 Dec.
9
Are low triglyceride levels the cause or an outcome of advanced liver fibrosis in elderly patients with nonalcoholic fatty liver disease?低甘油三酯水平是老年非酒精性脂肪性肝病患者晚期肝纤维化的原因还是结果?
J Gastroenterol Hepatol. 2020 Sep;35(9):1459-1460. doi: 10.1111/jgh.15226.
10
The role of the gut microbiome in graft fibrosis after pediatric liver transplantation.肠道微生物组在儿童肝移植后移植物纤维化中的作用。
Hum Genet. 2021 May;140(5):709-724. doi: 10.1007/s00439-020-02221-8. Epub 2020 Sep 13.